Press Releases
Press Releases
More Press Releases
View Older Stories View Newer Stories-
Learn CW Investment Corporation Announces Intention to Transfer Listing to Nasdaq
-
Gap Inc. Announces Third Quarter Dividend
-
Vishay Intertechnology Declares Quarterly Dividend
-
Kohl’s Declares Quarterly Dividend
-
Duos Technologies Group Reports Second Quarter 2024 Results
-
City of Houston Launches Initiative with Daikin to Equip Homes with Advanced Air Conditioning and Heating Solutions, Providing More Comfort and Energy Efficiency for Homeowners
-
Sable Offshore Corp. Reports Second Quarter 2024 Financial and Operational Results
-
Emerson Completes Sale of Remaining Interest in Copeland to Blackstone
-
Cleveland-Cliffs Inc. Announces Upsizing and Pricing of an Additional $600 Million Senior Guaranteed Notes due 2032
-
Intrusion Inc. Reports Second Quarter 2024 Results
-
KindlyMD to Present at Upcoming August 2024 Investor Conferences
-
Optex Systems Holdings, Inc. Announces Financial Highlights for the Three and Nine months Ended June 30, 2024
-
Panbela Provides Business Update and Reports Q2 2024 Financial Results
-
Doma Reports Second Quarter 2024 Financial Results
-
John B. Sanfilippo & Son, Inc. 4th Quarter and Full-Year 2024 Operating Results Conference Call
-
Cheetah Net Supply Chain Service Inc. Announces Second Quarter 2024 Results and Provides Corporate Update
-
The Westaim Corporation Reports Q2 2024 Results
-
SELLAS Life Sciences Reports Second Quarter 2024 Financial Results and Provides Corporate Update
-
Core Scientific, Inc. to Participate in the 44th Annual Cannacord Genuity Growth Conference
-
Ibotta Reports Second Quarter 2024 Financial Results
-
John B. Sanfilippo & Son, Inc. 4th Quarter and Full-Year 2024 Operating Results Conference Call
-
Solid Biosciences Reports Second Quarter 2024 Financial Results and Provides Business Updates
-
Key Tronic Corporation Announces Results for the Fourth Quarter of Fiscal Year 2024
-
Amkor Technology Declares Quarterly Dividend
-
UPDATE -- Firefly Neuroscience CEO Issues Letter to Stockholders Following Closing of Merger and Listing on Nasdaq
-
Conifex Announces Second Quarter 2024 Results
-
Intellinetics Grows 2024 Revenues 9.0% for Second Quarter of 2024
-
Accelerate AI Adoption and ROI With Info-Tech Research Group's Newly Launched AI Marketplace Research Center
-
Fortress Biotech Reports Second Quarter 2024 Financial Results and Recent Corporate Highlights
-
Glass House Brands Reports Record Setting Second Quarter 2024 Financial Results
-
Jones Soda Reports Second Quarter 2024 Results
-
ANI Pharmaceuticals, Inc. Closes $316.25 Million Convertible Senior Notes Offering Including Full Exercise of Initial Purchasers’ Option to Purchase Additional Notes
-
Senti Bio Announces Second Quarter 2024 Results and Reviews Recent Corporate and Pipeline Highlights
-
Alumis Reports Second Quarter 2024 Financial Results and Highlights Recent Development and Corporate Achievements
-
LogicMark, Inc. Announces Second Quarter 2024 Financial Results; Expansion Strategy into Personal Safety Markets Continues
-
Psychemedics Corporation Reports Second Quarter 2024 Financial Results
-
CNB Financial Corporation Announces Quarterly Dividend for Common Stock
-
Trinity Biotech to Announce Q2 2024 Financial Results
-
Dyadic Announces Second Quarter 2024 Financial Results and Highlights Recent Company Progress
-
Global Crossing Airlines Reports Second Quarter 2024 Financial Results
-
NeuroPace Reports Second Quarter 2024 Financial Results and Increases 2024 Revenue Guidance
-
Reed’s Reports Second Quarter 2024 Results
-
Schwazze Announces Second Quarter 2024 Financial Results
-
Mineralys Therapeutics Reports Second Quarter 2024 Financial Results and Provides Corporate Update
-
ImmuCell Announces Unaudited Financial Results for the Quarter Ended June 30, 2024
-
Universal Technical Institute, Inc. Announces Upcoming Investor Marketing Schedule
-
BGC Group Announces its 2024 Virtual Annual Meeting of Stockholders
-
Serve Robotics Announces Second Quarter 2024 Results
-
Mobile Infrastructure Reports Second Quarter 2024 Financial Results
-
Tenax Therapeutics Reports Second Quarter 2024 Financial Results and Provides a Corporate Update


